Ig Treatment Planning


Want a discount? Become a member by purchasing Corporate Membership, Enterprise Corporate Membership or Individual Membership!



Jointly provided by Partners for Advancing Clinical Education (PACE) and Ig National Society, Inc.

Original Release Date: May 2018
Release Date: February 2024
Expiration Date: February 2025

Speaker: Jan Ellen Jones, MSN, RN, IgCN®
Speaker: Lou Anne Epperson, MSN, RN, IgCN®

Continuing Education: Nursing 1.0 contact hour | Pharmacy 1.0 contact hour |  Physician 1.0 AMA PRA Category 1 Credit(s)™

Recertification: 1 IgCN® / IgCP® Recertification Units

Target Audience

This activity is intended for physicians, nurses, pharmacists, and other healthcare professionals who care for patients in need of immunoglobulin therapy and specialty biologics.

Educational Objectives                                                   

Upon completion of this activity, participants should be able to:

  • Recognize the importance of a systematic and standardized approach to Ig therapy treatment planning.
  • Identify the key parameters involved in treatment planning, including risk factor assessment, administration management, site of care consideration, patient education requirements, and cultural perspectives.
  • Integrate the identified parameters into the treatment planning process for Ig therapy, ensuring optimal patient outcomes and satisfaction.